Huang Ning

Ms. Huang Ning


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2008 in Molecules
Verified
Journal Article
Open access
PDF file
YLYang Li
Yang Li
YZYan-Li Zhao
Yan-Li Zhao
HNHuang Ning
Huang Ning
YZYong-Tang Zheng
Yong-Tang Zheng
YYYongping Yang
Yongping Yang
XLXiao-Li Li
Xiao-Li Li
Two new phenolic glycosides, 1-O-benzyl-[5-O-benzoyl-β-D-apiofuranosyl (1→2)]-β-D-glucopyranoside (1), and 4`-hydroxy-7,3`-dimethoxyflavan-5-O- β-D-gluco-pyranoside (2), together with nine known flavanones 3 - 11, have been isolated from the dried whole plants of Viscum articulatum.Their structures were identified by extensive spectral analysis, especially 2D NMR techniques. Compound 9 showed weak anti-HIV-1 activity.

20 April 2021 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
YRYan Xin Ren
Yan Xin Ren
JYJie Yang
Jie Yang
WSWei-Ze Sun
Wei-Ze Sun
YCYun Chen
Yun Chen
XWXi-Fang Wu
Xi-Fang Wu
XLXiaojiang Li
Xiaojiang Li
The standard approach to thyroidectomy is a collar incision via the anterior neck, and the neck scar has always been a source of worry for patients. Acceptable wound cosmetology has become a focus for thyroid surgeons. To verify the effectiveness and cosmetic results of thyroidectomy through a lateral supraclavicular incision. 180 patients were randomly divided into two groups: a lateral supraclavicular approach and a conventional transcervical approach. The main outcomes included incision length, intraoperative blood loss, operative time, total drainage volume, hospitalization expense, early postoperative pain measured by visual analog scale, infection, and perceived cosmetic outcome. There were no statistical significances between the two groups in terms of age, gender, nodule size, intraoperative blood loss, operative time, total drainage volume, hospital expense and postoperative complications, whereas there were significant differences in terms of incision length (5.2±1.04cm vs. 6.9±1.14cm, p<0.05). The lateral supraclavicular incision is a safe and feasible approach for thyroidectomy. Compared with conventional approach, it provides a better cosmetic result.

27 November 2024 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
XZXiaoyan Zhao
Xiaoyan Zhao
LTLing Tian
Ling Tian
YCYun Chen
Yun Chen
QYQing Yang
Qing Yang
TXTao Xie
Tao Xie
YRYan Xin Ren
Yan Xin Ren
Background: Nasopharyngeal carcinoma (NPC) is a prevalent form of head and neck cancer, particularly in specific regions with a higher incidence. The optimal treatment strategy for locally advanced NPC (stage III and IVA, LA-NPC) involves various combinations of induction chemotherapy (IC), concurrent chemoradiotherapy (CCRT), and adjuvant chemotherapy (AC), each with distinct advantages. This one institutional study aims to retrospectively analysis the efficacy and clinical outcomes of IC with CCRT (IC+CCRT), CCRT with AC (CCRT+AC), and the comprehensive approach of IC followed by CCRT and subsequently AC (IC+CCRT+AC) in the management of LA-NPC.Materials and methods: A total of 352 LA-NPC patients were included: 173 accepted IC+CCRT, 60 received CCRT+AC, and 119 underwent IC+CCRT+AC. The primary endpoints including overall survival (OS) and progression-free survival (PFS), were assessed using the Kaplan-Meier method and log-rank test.Results: The median follow-up was 61.2 months (1-216 months). There was no significant difference in 5-year OS and PFS between IC group and no IC group, extending the observation time to 90 months, the OS and PFS were significantly better in IC group than no IC group (OS: 76% vs. 70%,P<0.05; PFS: 76% vs. 71%, P<0.05). Patients with 1, 2, or 3 cycles of IC had higher 5-year OS and PFS than those with more than 3 cycles (1-4 cycles IC OS: 89% vs. 87% vs. 88% vs. 79%, P<0.05; 1-4 cycles IC PFS: 87% vs. 85% vs. 85% vs. 70%, P<0.05). NP regimen demonstrated higher OS and PFS than TP, PF, and TPF regimens (OS: 95% vs. 82% vs. 85% vs. 71%, P<0.05; PFS: 93% vs. 83% vs. 81% vs. 80%, P<0.05). The 5-year OS and PFS were significantly better in AC group than no AC group (OS: 82% vs. 72%, P<0.05; PFS: 81% vs. 69%, P<0.05). In the AC group, there was no differential effect of chemotherapy cycles and chemotherapy regimens on patients’ OS and PFS. In the ThNh group, patients receiving IC+CCRT+AC had higher OS and PFS compared to those receiving IC+CCRT, with no significant difference in the rest (OS: 85% VS 66% P<0.05; PFS: 78% VS 62%, P<0.05).Conclusion: CCRT combined with IC or AC could benefit LA-NPC patients. The IC+CCRT +AC regimen was most beneficial for NPC patients with later T and N stages.

18 February 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
QQQiu Qin
Qiu Qin
XYXingYu Yang
XingYu Yang
XLXiaojiang Li
Xiaojiang Li
YRYan Xin Ren
Yan Xin Ren
HNHuang Ning
Huang Ning
Purpose Nasopharyngeal carcinoma is a common clinical malignant tumour in the nasopharynx. The secretion of vIL-10 by EB virus can promote the development of nasopharyngeal carcinoma. The purpose of this study was to provide a theoretical basis for potential targets and mechanisms of vIL-10 in nasopharyngeal carcinoma. Methods A total of 100 ng/mL vIL-10 was applied to the nasopharyngeal carcinoma CNE-2 cell line for 48 h, and then whole transcriptome sequencing analysis was performed to identify potential targets and signalling pathways of vIL-10 in nasopharyngeal carcinoma. The effects of vIL-10 on the proliferation, migration, invasion and apoptosis of human nasopharyngeal carcinoma cells were determined by ELISA, Ki67 immunofluorescence, colony formation, transwell migration/invasion, Hoechst 33,258 staining, flow cytometry and other experiments, and the potential effects of vIL-10 on nasopharyngeal carcinoma cells were verified at the cellular level. Western blotting was performed to measure the changes in key factors of the JAK1-STAT3 signalling pathway in nasopharyngeal carcinoma cells after vIL-10 treatment. Results The whole transcriptome gene sequencing results showed that vIL-10 could effectively activate the JAK-STAT signalling pathway and upregulate the expression of JAK1 and STAT3. Moreover, vIL-10 inhibited the apoptosis of nasopharyngeal carcinoma cells, enhanced their migration and invasion capabilities, and further promoted the proliferation of nasopharyngeal carcinoma cells. Conclusion vIL-10 regulates the JAK1-STAT3 signalling pathway, promotes the proliferation of NPC cells, enhances their migration and invasion capabilities, inhibits tumour cell apoptosis, and participates in the progression of nasopharyngeal carcinoma.

1 January 2025 in Medicine Science | International Medical Journal
Verified
Journal Article
Open access
PDF file
YLYang-Chun Li
Yang-Chun Li
CZChao-Cai Zhang
Chao-Cai Zhang
WLWen-Jie Li
Wen-Jie Li
MYMeng Yang
Meng Yang
JMJia-Qing Ma
Jia-Qing Ma
HNHuang Ning
Huang Ning
Cancer immunotherapy represents a more advanced and effective treatment modality compared to traditional therapies, playing a significant role in the management of patients with nasopharyngeal carcinoma. However, the efficacy of immunotherapy can be influenced by the 'double-edged sword' nature of the immune system and the individual differences among cancer patients. To assess the efficacy and safety of immunotherapy in patients with nasopharyngeal carcinoma, we conducted a systematic review and meta-analysis of published clinical studies. Clinical research literature related to nasopharyngeal carcinoma immunotherapy was searched in the PubMed, Web of Science, Embase, and Cochrane databases up until December 2010. The literature was screened rigorously according to predefined inclusion and exclusion criteria. Quality evaluation of the included studies was conducted using the Newcastle-Ottawa Scale (NOS), and studies meeting the inclusion criteria were extracted for analysis and evaluation. The Chi-square test and I2 statistic were utilized to assess heterogeneity, while publication bias was examined through the construction of a funnel plot and the application of the Egger test. A total of 19 studies were included in this meta-analysis, including 2,354 patients with nasopharyngeal carcinoma. The results showed that immunotherapy had a good therapeutic effects on patients with nasopharyngeal carcinoma. The 0.5-3 year PFS of patients with nasopharyngeal carcinoma who received immunotherapy was significantly improved compared to the group who did not receive immunotherapy (OR: 1.87; 95% CI 1.22-2.85) and 0.5-3 year OS were also significantly improved (OR: 1.45; 95% CI 1.23-1.74). In terms of treatment-related adverse events (AEs), the incidence of ≥ grade 3 treatment-related AEs was 27% (95% CI 25-30%), and the incidence of combination therapy was higher than that of monotherapy. In the treatment of patients with nasopharyngeal carcinoma, immunotherapy has demonstrated superior efficacy compared to chemotherapy alone. Furthermore, the expression levels of EBV DNA and PD-L1 in the serum of patients significantly influence the therapeutic outcomes.

1 November 2022 in Brazilian Journal of Otorhinolaryngology (Versão em Português)
Verified
Journal Article
Closed access
YRYan Xin Ren
Yan Xin Ren
JYJie Yang
Jie Yang
WSWei‐Ze Sun
Wei‐Ze Sun
YCYun Chen
Yun Chen
XWXi‐Fang Wu
Xi‐Fang Wu
XLXiaojiang Li
Xiaojiang Li